A New Use for GLP-1s? Amylyx Pharma Catapults To 3-Year High.

Amylyx stock skyrocketed Tuesday after its GLP-1 drug reduced hypoglycemia in patients who've undergone bariatric surgery. The post A New Use for GLP-1s? Amylyx Pharma Catapults To 3-Year High. appeared first on Investor's Business Daily.